Holding and investment company Novo Holdings has agreed to acquire a majority stake in aquaculture technology company Stingray Marine Solutions.
Novo Holdings had assets of EUR 149 billion (USD 163 million) as of the end of 2023, is wholly owned by the Novo Nordisk Foundation, and is the controlling shareholder of Novo Nordisk and Novonesis. The company said its latest investment in Stingray Marine Solutions was made by its Planetary Health Investments team and is the first time the team has invested in aquaculture technology.
"We're pleased to invest in a company that not only offers an innovative aquamarine technology solution to address industry needs but also places sustainability at the forefront of its approach – a pressing factor in the marine and aquaculture industries,” Novo Holdings Planetary Health Investments Partner Cynthia Kueppers said.
Stingray Marine Solutions creates products designed to tackle sea lice on salmon and is the developer behind a robotic laser system that zaps sea lice off of salmon. The company’s device was adopted by Cermaq in 2023 and has also been adopted by Nordlaks Group.
The system uses ...
